Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.40 +0.05 (+3.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Transcode Therapeutics (RNAZ) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Transcode Therapeutics (RNAZ) reported Return on Capital Employed [ROCE] of -30.35% for Q2 2026, up 129.49 percentage points from -159.84% a year earlier but down 2.79 percentage points from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Transcode Therapeutics posted Return on Capital Employed [ROCE] of -34.39%, up 418.19 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a four-year change of +30.61 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -452.59% in FY2024 (+219.74 pp), -672.33% in FY2023 (-501.63 pp), -170.70% in FY2022 (-105.70 pp) and -65.00% in FY2021.
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -1758.62% in Q1 2023 and a high of -27.57% in Q1 2026.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last six quarters, with an average year-over-year change of +245.96 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2024 (a gain of 1252.94 percentage points); the low point was Q1 2023 (a drop of 1710.42 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -27.57% (Q1 2026), -34.84% (Q4 2025) and -451.10% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Transcode Therapeutics 1.37 Mn -40.52 Mn - -30.35%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -30.35%
Mar 31, 2026 -27.57%
Dec 31, 2025 -34.84%
Sep 30, 2025 -451.10%
Jun 30, 2025 -159.84%
Mar 31, 2025 -200.95%
Dec 31, 2024 -550.76%
Sep 30, 2024 -699.57%
Jun 30, 2024 -697.04%
Mar 31, 2024 -505.68%
Dec 31, 2023 -461.45%
Sep 30, 2023 -847.40%
Jun 30, 2023 -924.69%
Mar 31, 2023 -1,758.62%
Dec 31, 2022 -341.62%
Sep 30, 2022 -173.12%
Jun 30, 2022 -91.58%
Mar 31, 2022 -48.20%
Dec 31, 2021 -28.46%
Sep 30, 2021 -31.54%
API Access

Transcode Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RNAZ&period=max&api_key=YOUR_API_KEY